TrialNature medicine2026

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial.

Rouchelle S Sriranjan-Rothwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.